Skip to main content

Table 5 Five- and ten-year overall survival and relapse-free survival according to co-expression patterns of nuclear IL4Rα and nuclear IL13Rα1

From: Expression of IL4Rα and IL13Rα1 are associated with poor prognosis of soft-tissue sarcoma of the extremities, superficial trunk, and retroperitoneum

Co-expression pattern of nIL4Rα and nIL13Rα1

No.

5y-OS (%)

10y-OS (%)

5y-RFS (%)

10y-RFS (%)

Co-expression Model 1

 nIL4Rα/nIL13Rα1, −/−

31

87

87

75

75

 nIL4Rα/nIL13Rα1,+/−

13

81

65

52

39

 nIL4Rα/nIL13Rα1, −/+

9

67

36

22

11

 nIL4Rα/nIL13Rα1, +/+

36

26

13

3

0

Co-expression Model 2

 nIL4Rα/nIL13Rα1, −/−

31

87

87

75

75

 nIL4Rα/nIL13Rα1, +/− or −/+

22

75

50

40

27

 nIL4Rα/nIL13Rα1, +/+

36

26

13

3

0

  1. Abbreviations: 5y-OS Overall survival rate at 5 years, 10y-OS Overall survival rate at 10 years, 5y-RFS Relapse-free survival rate at 5 years, 10y-RFS Relapse-free survival rate at 10 years, nIL4Rα Nuclear expression of IL4Rα, nIL13Rα1 Nuclear expression of IL13Rα1